Study of Circulating Microparticles in Giant Cell Arteritis
NCT02333708 · Status: UNKNOWN · Type: OBSERVATIONAL · Enrollment: 75
Last updated 2022-03-09
Summary
To demonstrate that microparticles (MPs), having a powerful procoagulant potential, are in larger amounts in the blood of patients with histologically proven giant cell arteritis (GCA), compared with patients matched for age, sex and with or without inflammatory syndrome.
Conditions
- Giant Cell Arteritis
- Acute Phase
Interventions
- OTHER
-
Blood sample
Sponsors & Collaborators
-
University Hospital, Caen
lead OTHER
Eligibility
- Min Age
- 18 Years
- Sex
- ALL
- Healthy Volunteers
- Yes
Timeline & Regulatory
- Start
- 2015-09-30
- Primary Completion
- 2023-09-16
- Completion
- 2023-11-30
Countries
- France
Study Locations
More Related Trials
-
Giant Cell Arteritis: Comparison Between Two Standardized Corticosteroids Tapering
NCT04012905 ·Status: NOT_YET_RECRUITING ·Phase: PHASE3
-
Giant Cell Arteritis and Anakinra Trial
NCT02902731 ·Status: TERMINATED ·Phase: PHASE3
-
Biomarkers in Giant Cells Arteritis
NCT02844023 ·Status: TERMINATED ·Phase: NA
-
Methotrexate as Remission Maintenance Therapy After Remission-Induction With Tocilizumab and Glucocorticoids in Giant Cell Arteritis
NCT05623592 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE2
-
Determining Disease Activity Biomarkers in Individuals With Giant Cell Arteritis
NCT00315497 ·Status: COMPLETED
-
Neutrophils as Prognostic Factors in Granulomatosis With Polyangiitis (Formerly Named Wegener's Granulomatosis)
NCT01862068 ·Status: COMPLETED
-
Intravenous Immunoglobulin After Relapse in Vasculitis
NCT00307658 ·Status: TERMINATED ·Phase: PHASE3
-
Rituximab Plus Corticosteroids in Non-infectious Active Mixed Cryoglobulinemia Vasculitis
NCT02556866 ·Status: TERMINATED ·Phase: PHASE2
-
TARGET GCAT Registry
NCT04049071 ·Status: TERMINATED
-
Steroids Pharmacokinetics and the Response to Prednisone Therapy in Giant Cell Arteritis
NCT01400464 ·Status: UNKNOWN ·Phase: PHASE4
-
A Study to Evaluate the Safety and Efficacy of Upadacitinib in Participants With Giant Cell Arteritis
NCT03725202 ·Status: COMPLETED ·Phase: PHASE3
-
Clinical Study of Anti-tumor Necrosis Factor Therapy in Patients With Takayasu Arteritis
NCT02457585 ·Status: UNKNOWN ·Phase: PHASE2
-
Comparison Study of Two Rituximab Regimens in the Remission of ANCA Associated Vasculitis
NCT01731561 ·Status: COMPLETED ·Phase: PHASE3
-
Tocilizumab Dose-tapering and Interruption in Patients With Giant Cell Arteritis Achieving the Clinical Remission.
NCT03244709 ·Status: UNKNOWN ·Phase: PHASE4
-
TocilizuMab discontinuAtion in GIant Cell Arteritis
NCT06037460 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE3
-
The Role of the Coagulation Pathways in Recurrent Angioedema
NCT02892682 ·Status: TERMINATED ·Phase: NA
-
Aetiology of TemporaL Arteritis Study
NCT02584517 ·Status: WITHDRAWN
-
Bosentan in the Treatment of Giant Cell Arteritis
NCT06957002 ·Status: NOT_YET_RECRUITING ·Phase: PHASE2
-
Tocilizumab for Patients With Giant Cell Arteritis
NCT01450137 ·Status: COMPLETED ·Phase: PHASE2
-
Association of Ultrasonographic Temporal Artery Lesions and Relapse in Patients With Giant Cell Arteritis
NCT06894602 ·Status: RECRUITING
-
Giant Cell Arteritis and Differential Diagnoses Associated With Positive Temporal Artery Biopsy
NCT04554290 ·Status: COMPLETED
-
Rapid Diagnostic Test for Septic Arthritis
NCT04460144 ·Status: COMPLETED
-
Pharmacokinetic Study of Rituximab Induction Regimen in ANCA-associated Vasculitis
NCT02474888 ·Status: TERMINATED
-
Treatment of Necrotizing Vasculitides for Patients Older Than 65 Years
NCT00307671 ·Status: COMPLETED ·Phase: PHASE4
-
Efficacy and Tolerance of Tocilizumab In Takayasu Arteritis
NCT02101333 ·Status: COMPLETED ·Phase: PHASE3